Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
GM Crops ; 2(3): 211-24, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22179194

RESUMO

Cowpea (Vigna unguiculata spp unguiculata) is adapted to the drier agro-ecological zones of West Africa where it is a major source of dietary protein and widely used as a fodder crop. Improving the productivity of cowpea can enhance food availability and security in West Africa. Insect predation--predominately from the legume pod borer (Maruca vitrata), flower thrips (Megalurothrips sjostedti) and a complex of pod-sucking bugs (e.g., Clavigralla spp)--is a major yield-limiting factor in West African cowpea production. Dramatic increases in yield are shown when M. vitrata is controlled with insecticides. However, availability, costs, and safety considerations limit pesticides as a viable option for boosting cowpea production. Development of Bt-cowpea through genetic modification (GM) to control the legume pod borer is a promising approach to cowpea improvement. Cowpea expressing the lepidopteran-active Cry1Ab protein from Bacillus thuringiensis is being developed as a first generation Bt-cowpea crop for West Africa. Appropriate stewardship of Bt-cowpea to assure its sustainability under West African conditions is critical to its successful development. A first step in this process is an environmental risk assessment to determine the likelihood and magnitude of adverse effects of the Cry1Ab protein on key environmental protection goals in West Africa. Here we describe the results of an expert panel convened in 2009 to develop the problem formulation phase for Bt-cowpea and to address specific issues around gene flow, non-target arthropods, and insect resistance management.


Assuntos
Proteínas de Bactérias/genética , Endotoxinas/genética , Fabaceae/genética , Proteínas Hemolisinas/genética , Plantas Geneticamente Modificadas/genética , África Ocidental , Animais , Bacillus thuringiensis/genética , Toxinas de Bacillus thuringiensis , Produtos Agrícolas/genética , Produtos Agrícolas/crescimento & desenvolvimento , Monitoramento Ambiental/legislação & jurisprudência , Monitoramento Ambiental/métodos , Fabaceae/crescimento & desenvolvimento , Fabaceae/parasitologia , Expressão Gênica , Fluxo Gênico , Interações Hospedeiro-Parasita , Hibridização Genética , Insetos/fisiologia , Controle Biológico de Vetores/economia , Controle Biológico de Vetores/legislação & jurisprudência , Controle Biológico de Vetores/métodos , Doenças das Plantas/genética , Doenças das Plantas/parasitologia , Plantas Geneticamente Modificadas/crescimento & desenvolvimento , Plantas Geneticamente Modificadas/parasitologia , Medição de Risco/legislação & jurisprudência , Medição de Risco/métodos
2.
Transgenic Res ; 20(1): 1-22, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20938806

RESUMO

This paper provides recommendations on experimental design for early-tier laboratory studies used in risk assessments to evaluate potential adverse impacts of arthropod-resistant genetically engineered (GE) plants on non-target arthropods (NTAs). While we rely heavily on the currently used proteins from Bacillus thuringiensis (Bt) in this discussion, the concepts apply to other arthropod-active proteins. A risk may exist if the newly acquired trait of the GE plant has adverse effects on NTAs when they are exposed to the arthropod-active protein. Typically, the risk assessment follows a tiered approach that starts with laboratory studies under worst-case exposure conditions; such studies have a high ability to detect adverse effects on non-target species. Clear guidance on how such data are produced in laboratory studies assists the product developers and risk assessors. The studies should be reproducible and test clearly defined risk hypotheses. These properties contribute to the robustness of, and confidence in, environmental risk assessments for GE plants. Data from NTA studies, collected during the analysis phase of an environmental risk assessment, are critical to the outcome of the assessment and ultimately the decision taken by regulatory authorities on the release of a GE plant. Confidence in the results of early-tier laboratory studies is a precondition for the acceptance of data across regulatory jurisdictions and should encourage agencies to share useful information and thus avoid redundant testing.


Assuntos
Artrópodes/efeitos dos fármacos , Plantas Geneticamente Modificadas/toxicidade , Projetos de Pesquisa/normas , Animais , Bacillus thuringiensis , Produtos Agrícolas/genética , Guias como Assunto , Laboratórios , Plantas Geneticamente Modificadas/parasitologia , Medição de Risco/métodos , Medição de Risco/normas
3.
Nat Biotechnol ; 26(2): 203-8, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18259178

RESUMO

An international initiative is developing a scientifically rigorous approach to evaluate the potential risks to nontarget arthropods (NTAs) posed by insect-resistant, genetically modified (IRGM) crops. It adapts the tiered approach to risk assessment that is used internationally within regulatory toxicology and environmental sciences. The approach focuses on the formulation and testing of clearly stated risk hypotheses, making maximum use of available data and using formal decision guidelines to progress between testing stages (or tiers). It is intended to provide guidance to regulatory agencies that are currently developing their own NTA risk assessment guidelines for IRGM crops and to help harmonize regulatory requirements between different countries and different regions of the world.


Assuntos
Artrópodes/efeitos dos fármacos , Toxinas Bacterianas/toxicidade , Controle Biológico de Vetores , Plantas Geneticamente Modificadas/toxicidade , Medição de Risco/métodos , Animais , Toxinas Bacterianas/genética , Marcação de Genes/métodos , Plantas Geneticamente Modificadas/parasitologia , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA